A new trading day began on Monday, with Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) stock price down -6.35% from the previous day of trading, before settling in for the closing price of $18.91. ARWR’s price has ranged from $17.05 to $36.72 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -2.87% over the last five years. Meanwhile, its annual earnings per share averaged 46.57%. With a float of $104.95 million, this company’s outstanding shares have now reached $125.57 million.
The firm has a total of 609 workers. Let’s measure their productivity. In terms of profitability, gross margin is -272.28%, operating margin of -25037.88%, and the pretax margin is -25870.12%.
Arrowhead Pharmaceuticals Inc (ARWR) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Arrowhead Pharmaceuticals Inc is 16.77%, while institutional ownership is 77.04%. The most recent insider transaction that took place on Mar 03 ’25, was worth 3,004,203. Before that another transaction happened on Jan 23 ’25, when Company’s Director sold 959 for $21.00, making the entire transaction worth $20,139. This insider now owns 35,781 shares in total.
Arrowhead Pharmaceuticals Inc (ARWR) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 46.57% per share during the next fiscal year.
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Trading Performance Indicators
Here are Arrowhead Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 893.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.15, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -3.74 in one year’s time.
Technical Analysis of Arrowhead Pharmaceuticals Inc (ARWR)
Analysing the last 5-days average volume posted by the [Arrowhead Pharmaceuticals Inc, ARWR], we can find that recorded value of 1.34 million was lower than the volume posted last year of 2.02 million. As of the previous 9 days, the stock’s Stochastic %D was 11.40%. Additionally, its Average True Range was 1.09.
During the past 100 days, Arrowhead Pharmaceuticals Inc’s (ARWR) raw stochastic average was set at 6.41%, which indicates a significant increase from 3.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.56% in the past 14 days, which was lower than the 68.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.63, while its 200-day Moving Average is $22.30. Now, the first resistance to watch is $18.58. This is followed by the second major resistance level at $19.46. The third major resistance level sits at $19.94. If the price goes on to break the first support level at $17.22, it is likely to go to the next support level at $16.74. Now, if the price goes above the second support level, the third support stands at $15.86.
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Key Stats
With a market capitalization of 2.23 billion, the company has a total of 126,098K Shares Outstanding. Currently, annual sales are 3,550 K while annual income is -599,490 K. The company’s previous quarter sales were 2,500 K while its latest quarter income was -173,090 K.
